Tag: Maternofetal Hematology

  • Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT

    Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT

    Tabea

    Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) is a disorder caused by maternal alloantibodies directed against paternally inherited fetal platelet antigens, most commonly human platelet antigen-1a (HPA-1a). These antibodies cross the placenta, leading to fetal thrombocytopenia and an increased risk of intracranial hemorrhage and other bleeding complications. Rallybio has announced on April 8th to discontinue the… Read more